Evaluation of the Glucoregulatory Effects of GLP-1 Receptor Activation in Patients With Type 2 Diabetes Mellitus.
Phase of Trial: Phase I
Latest Information Update: 06 Dec 2013
At a glance
- Drugs Oxyntomodulin (Primary) ; Liraglutide
- Indications Type 2 diabetes mellitus
- Focus Pharmacodynamics
- Sponsors Merck Sharp & Dohme
- 10 Jun 2017 Biomarkers information updated
- 24 Sep 2013 Results presented at the 49th Annual Meeting of the European Association for the Study of Diabetes.
- 05 Jul 2013 Primary endpoint added as reported by ClinicalTrials.gov.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History